Reason for request
Renewal of inclusion on the list of reimbursable medicinal products.
Clinical Benefit
| Insufficient |
The actual benefit of the proprietary medicines MAGNE B6 for oral administration, is insufficient to be reimbursed by national solidarity. |
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
qtjq15eExtMG1WM4
Listen
